Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

BACKGROUND: HMG-CoA reductase inhibitors (statins) are commonly used in medicine to control blood lipid disorder. Large clinical trials have demonstrated that statins greatly reduces cardiovascular-related morbidity and mortality in patients with and without coronary artery disease. Also, the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Noël, Martin, Gagné, Claude, Bergeron, Jean, Jobin, Jean, Poirier, Paul
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Short Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC425594/
https://www.ncbi.nlm.nih.gov/pubmed/15134579
http://dx.doi.org/10.1186/1476-511X-3-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC425594/
https://www.ncbi.nlm.nih.gov/pubmed/15134579
http://dx.doi.org/10.1186/1476-511X-3-7

Ejemplares similares